Investigating how certain proteins interact in Alzheimer's disease

Eph and Lyn hyper-phosphorylation and CRMP interactions in AD"

NIH-funded research Case Western Reserve University · NIH-10886829

This study is looking at how certain proteins in the brain interact and change in ways that might contribute to Alzheimer's disease, with the hope of finding new ways to treat or diagnose the condition.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionCase Western Reserve University NIH-funded
Lab location1 site (Cleveland, United States)
Project IDNIH-10886829 on NIH RePORTER

What this research studies

This research focuses on understanding the interactions between Eph receptors and a protein called CRMP, which are believed to play a role in Alzheimer's disease. The study aims to explore how these proteins become hyper-phosphorylated and how this affects cell structure and function in the brain. By examining these interactions in a laboratory setting, researchers hope to identify potential biomarkers and therapeutic targets that could lead to new treatments for Alzheimer's. The research involves detailed analysis of protein behavior and cellular responses to better understand the underlying mechanisms of the disease.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those at risk of developing it.

Not a fit: Patients with other forms of dementia unrelated to Alzheimer's may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for treating Alzheimer's disease.

How similar studies have performed: Previous research has shown promising results in understanding protein interactions in neurodegenerative diseases, suggesting potential for success in this area.

Where this research is happening

Cleveland, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.